Biotech

All Articles

Daiichi pays for Merck $170M to develop bronchi cancer T-cell engager contract

.Merck &amp Co. has actually rapidly recovered a few of the costs of its own Javelin Therapeutics bu...

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin administered a springtime well-maintained of its pipeline in April, the business has...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Big Pharmas stay stuck to the suggestion of molecular glue degraders. The most recent provider to f...

Life scientific research credit scores agency unveils with $600M

.A brand new global lifestyle scientific research credit history company, referred to Symbiotic Fina...

BMS ditches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing yet another big bet from the Caforio era, canceling an offer for Agen...

Nuvation stops BET prevention after looking at stage 1 record

.After looking at period 1 information, Nuvation Biography has actually made a decision to stop work...

' Professional intuitiveness' led FDA experts to support Zevra's uncommon condition med

.Zevra Therapeutics' uncommon ailment medicine seems to be to become on the road to confirmation thi...

Pfizer takes $230M hit after axing failed DMD gene treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has actually gone a $230 ...

AC Immune views 'spots' prospective in Alzheimer's drug information

.After much more than twenty years of deal with neurodegenerative conditions, Swiss biotech air cond...

GSK falls ph. 2 HPV vaccination over absence of best-in-class prospective

.GSK has junked a phase 2 human papillomavirus (HPV) vaccination from its own pipeline after determi...